In addition, calcineurin inhibitors also exhibit inhibitory signaling through calcineurin and nuclear factor of activated T-cells, resulting in p53 activation, a crucial checkpoint in the progression of non-melanoma skin cancer [33]. This evidence concerns the gene TP53 and non-melanoma skin carcinoma.